ClinicalTrials.gov
ClinicalTrials.gov Menu

Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02523014
Recruitment Status : Suspended (No arms are currently open to patient registration)
First Posted : August 14, 2015
Last Update Posted : September 6, 2018
Sponsor:
Collaborators:
National Cancer Institute (NCI)
GlaxoSmithKline
Genentech, Inc.
Brain Science Foundation
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : August 2019
  Study Completion Date : No date given